There are 3,110 papers on bone fracture in aging research: 145 trials and 1,539 observational studies in people, 180 in animals, 6 in cells, 1,091 reviews. The newest story, Nov 18, 2026: “Osteoporosis risk varied with weight and metabolic health”.
Antiosteoporosis medications reduce fractures across pooled human trials; individual trials also report reductions with dairy foods and with exercise in women. A trial of a multicomponent intervention reports more fractures, whereas another finds no clear effect of multivitamin–multimineral supplements or cocoa extract. Human observational studies link frailty, dementia, and underweight with higher fracture risk.
996 findings in 728 papers from 1995 to 2026, 119 of them since April 2026
“Tirzepatide was associated with higher fracture odds (Peto OR 1.84, 95% CI 1.02-3.31; I2=25%; p=0.04).”
Vitamin D showed no clear effect on bone fracture in humans (HR 1.06, 95% CI 0.57-1.99).
“A fracture occurred in 20 participants (0.2 per 100 person years) assigned to vitamin D, and 19 (0.1 per 100 person years) assigned to placebo (HR 1.06, 95% CI 0.57-1.99, p-value = 0.86).”
Human trial60,000 IU monthlymean 4.6 yearsn = 5,670
Nutrition, metabolism, and cardiovascular diseases : NMCD·
Vitamin D showed no clear effect on bone fracture in humans (healthy adults not recruited based on vitamin D deficiency, low bone mass, or osteoporosis).
“supplemental vitamin D didn't lower the risk of total, nonvertebral, or hip fractures compared with placebo.”
Human trialhealthy adults not recruited based on vitamin D deficiency, low bone mass, or osteoporosis
Vitamin D showed no clear effect on bone fracture in vitamin D-replete populations.
“recent large-scale randomized controlled trials have failed to replicate the broad benefits previously observed in epidemiological studies, particularly with respect to fracture and fall prevention in vitamin D-replete populations”
Vitamin D showed no clear effect on bone fracture in humans (OR 1.12, 95% CI 0.97-1.29, p=0.11).
“showed a 12% (OR=1.12; 95% CI, 0.97-1.29; p=0.11) decrease in the odds of having at least one fracture among older adults; however, the difference was also not statistically significant”
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·
Vitamin D showed no clear effect on bone fracture in vitamin D-replete and healthy individuals.
“failed to detect any efficacy of these approaches for the prevention of fracture and falls”
Reviewin vitamin D-replete and healthy individualsoral2000 to 100,000 IU/month
SGLT2 inhibitors were not clearly linked with bone fracture in humans (compared with glp-1 receptor agonists in postmenopausal individuals with type 2 diabetes) (weighted HR 0.92 (95% CI 0.68-1.24)).
“no association with an increased risk of overall fractures was presented with SGLT2i vs GLP1RA (weighted HR, 0.92; 95% CI, 0.68-1.24)”
Humanscompared with glp-1 receptor agonists in postmenopausal individuals with type 2 diabetesn = 8,177
SGLT2 inhibitors were not clearly linked with bone fracture in humans (versus dipeptidyl peptidase 4 inhibitor new users) (HR 0.90 (95% CI 0.73-1.11)).
“There was no difference in the risk of fracture in SGLT-2i users compared with DPP-4i users (HR, 0.90; 95% CI, 0.73-1.11) or GLP-1RA users (HR, 1.00; 95% CI, 0.80-1.25).”
Humansversus dipeptidyl peptidase 4 inhibitor new users
SGLT2 inhibitors showed no clear effect on bone fracture in adults with type 2 diabetes, chronic kidney disease, or heart failure (RR 1.087, 95% CI 0.973–1.214).
“SGLT-2i were not associated with increased fracture risk (pooled RR 1.087, 95% CI 0.973–1.214; P = 0.141; I2 = 41.7%).”
Reviewin adults with type 2 diabetes, chronic kidney disease, or heart failuren = 62,583
Hormone replacement therapy protects against bone fracture in humans.
“majority of women who might benefit from the protective effects of MHT against bone loss and fracture are not offered this treatment option if they do not fit with these criteria.”
GLP-1 receptor agonists were not clearly linked with bone fracture in humans (patients with type 2 diabetes; compared with SGLT-2 inhibitors) (standardized risk ratio 0.90 (95% CI 0.79-1.01)).
“1-year risks of fractures, bradyarrhythmia, and cardiac device implantation were equally low and with corresponding standardized risk ratios of 0.90 (95% CI: 0.79-1.01)”
Humanspatients with type 2 diabetes; compared with SGLT-2 inhibitors1 year
European heart journal. Cardiovascular pharmacotherapy·
GLP-1 receptor agonists were not clearly linked with bone fracture in humans (unadjusted analyses; fracture cases vs matched fracture-free controls) (OR 1.00 [0.97-1.04]).
“In the unadjusted analyses, GLP-1 receptor agonist use did not differ between cases and controls”
Humansunadjusted analyses; fracture cases vs matched fracture-free controlsn = 675,296
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·
GLP-1 receptor agonists were not clearly linked with bone fracture in humans (versus dipeptidyl peptidase-4 inhibitor users, after 1:1 propensity score matching).
“No significant differences were observed between the groups in the rate of heart failure or bone fractures.”
Humansversus dipeptidyl peptidase-4 inhibitor users, after 1:1 propensity score matchingup to 5 yearsn = 11,464
Cholecalciferol showed no clear effect on bone fracture in humans (HR 0.98 (95% CI 0.89–1.08, P = 0.70)).
“Supplemental vitamin D3, as compared with placebo, did not have a significant effect on total fractures (which occurred in 769 of 12,927 participants in the vitamin D group and in 782 of 12,944 participants in the placebo group; hazard ratio, 0.98; 95% confidence interval [CI], 0.89 to 1.08; P = 0.70)”
Human trial2000 IU per daymedian follow-up of 5.3 yearsn = 25,871
Romosozumab prevents bone fracture in humans (followed by an anti-resorptive).
“Romosozumab is given as monthly s.c. injections for 1 year, followed by an anti-resorptive. This sequence prevents more fractures than anti-resorptive therapy alone.”
Aspirin showed no clear effect on bone fracture in humans (healthy community-dwelling older adults) (HR 0.97, 95% CI 0.87-1.06).
“there was no difference in the risk of first fracture between the intervention and control participants (hazard ratio, 0.97; 95% CI, 0.87-1.06; P = .50)”
Human trialhealthy community-dwelling older adultsenteric-coated100 mg4.6 yearsn = 16,703
Aspirin was not clearly linked with bone fracture in humans (OR 0.963, 95% CI 0.08-1.149).
“The odds ratio of fractures due to a fall from standing height or less was 0.963 (95 percent confidence interval 0.08-1.149) in low-dose aspirin users”
Multifactorial fall injury prevention intervention showed no clear effect on bone fracture in humans (increased fall injury risk) (IRR 0.89, 95% CI 0.73-1.07, p = 0.205).
“0.89 (95% CI, 0.73-1.07; p = 0.205) for adjudicated fractures”
Omega-3 fatty acids showed no clear effect on bone fracture in humans (generally healthy adults without baseline cancer or cardiovascular disease) (HR 1.02, 95% CI 0.92-1.13).
“Supplemental omega-3 vs placebo had no effect on total (HR, 1.02; 95% CI, 0.92-1.13; p = .73), nonvertebral (HR, 1.01; 95% CI, 0.91-1.12; p = .80), or hip fractures”
Human trialgenerally healthy adults without baseline cancer or cardiovascular diseaseEPA+DHA in a 1.2:1 ratio1 g/dmedian 5.3 yrn = 25,871
Multivitamin-multimineral supplement showed no clear effect on bone fracture in humans (aHR 1.09, 95% CI 1.00-1.19).
“In Cox proportional hazards regression models, the adjusted hazard ratio (aHR) for total clinical fracture was 1.09 (95% CI 1.00-1.19) and for nonvertebral fracture was 1.10 (95% CI 1.00-1.20).”
Cocoa extract showed no clear effect on bone fracture in humans.
“After stratification of the baseline hazard function by age, sex, study assignment to MVM supplementation, and recruitment source, cocoa extract (vs cocoa extract placebo) was not significantly associated with incident clinical fracture.”
Intensive lifestyle intervention showed no clear effect on bone fracture in humans (HR = 0.992; 95% CI 0.679 – 1.449).
“In a sensitivity analysis of fracture risk in the DXA subgroup, neither incident total fracture (HR = 0.992; 95% CI 0.679 – 1.449; p = 0.9664) nor frailty fracture (1.199; 95% CI = (0.611 – 2.351); p = 0.5979) were statistically different between the ILI and DSE groups in this subset of Look AHEAD participants with DXA measurements (see Fig. a and b”
Bone fracture is linked with higher mortality in humans after lower extremity trauma (34% vs 8%, p < 0.001).
“the one-year mortality rate was 34%. In comparison, the age- and gender-matched one-year mortality rate of the general Swiss population was 8% (p < 0.001).”
Bone fracture was not clearly linked with hypertension in 2006-2015 cohort (adjusted HR 1.09 (95% CI 0.85-1.38)).
“In the analysis of the association between fracture and incident hypertension, the adjusted HRs (95% CIs) were 1.28 (0.96-1.72) in 1997-2015, 1.18 (0.94-1.49) in 2000-2015, 1.12 (0.89-1.40) in 2004-2015, and 1.09 (0.85-1.38) in 2006-2015.”
calendar time decreases bone fracture in silico (globally, 1990 to 2019) (-9.6% (95% UI -11.1 to -8.1)).
“The age-standardised rates of fractures in 2019 were 2296·2 incident cases (2091·1-2529·5) per 100 000 population (a decrease of 9·6% [8·1-11·1] since 1990)”
Bone fracture is associated with osteoporosis in humans (history of post-traumatic fractures).
“A history of fracture was significantly associated with osteoporosis status at both the lumbar spine and femoral neck, with a higher proportion of past fractures observed among participants with osteoporosis. (p < 0.05).”
Osteoporosis is linked with a higher risk of bone fracture in patients with T1DM (RR ≈ 6.92, 95% CI 5.09-9.39).
“In T1DM, fracture frequency was approximately sixfold higher in patients with osteoporosis than in those without osteoporosis (RR ≈ 6.92; 95% CI 5.09-9.39; p < 0.001)”
Osteoporosis predicts bone fracture in humans (RR=1.61; 95% CI: 1.04-2.48).
“In women, osteoporosis at the one-third radius independently predicted fracture risk (RR=1.61; 95% CI: 1.04-2.48), whereas spine or hip osteoporosis alone did not.”
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·
Bone fracture is linked with a higher risk of osteoporosis in humans (incident hemodialysis).
“Osteoporosis was significantly associated with female sex, a history of fractures, and the absence of phosphate binder use.”
Osteoporosis is linked with a higher risk of bone fracture in humans (adjusted for age, sex, BMI, behavior, handgrip strength, medications, comorbidities) (OR 1.89, 95% CI 1.23-3.47).
“Osteoporosis significantly increased the fracture risk across all types, except vertebral fracture, with adjusted OR (95% CI) of 1.89 (1.23-3.47) for any fracture”
Humansadjusted for age, sex, BMI, behavior, handgrip strength, medications, comorbidities
Falls are associated with bone fracture in humans (adjusted OR 1.83; 95% CL 1.13-2.97).
“The adjusted odds for self-reported incident fractures in participants of all ages was also significantly associated with falls in the past 12 months prior to baseline”
Hormone replacement therapy lowers the risk of bone fracture.
“hormone replacement therapy, vitamin D supplements, and lifestyle changes, are critical for maintaining good bone health and lowering the risk of fracture”
Journal of ISAKOS : joint disorders & orthopaedic sports medicine·
Hormone replacement therapy lowers the risk of bone fracture in humans (particularly the combination of estradiol and dydrogesterone).
“Clinical studies demonstrate a significant increase in bone mineral density and a reduction in the risk of fractures with the use of MHT, particularly the combination of estradiol and dydrogesterone.”
Reviewparticularly the combination of estradiol and dydrogesterone
The Journal of clinical endocrinology and metabolism·
Bone mineral density is linked with a lower risk of bone fracture in humans (CKD patients on dialysis (RRT)) (SHR 0.54, 95% CI 0.38-0.75).
“each one-unit increase in BMD T-score was associated with an approximately 45% lower fracture risk in both groups (RRT: SHR 0.54, 95% CI 0.38-0.75; non-RRT: SHR 0.57, 95% CI 0.41-0.79).”
HumansCKD patients on dialysis (RRT)median follow-up of 1,694 daysn = 514
Bone mineral density is linked with a lower risk of bone fracture in humans (HR 0.12, 95% CI 0.05-0.29).
“Higher NN BMD (HR:0.12, 95% CI:0.05-0.29), cross-sectional area (CSA) (0.37, 0.26-0.52), cross-sectional moment of inertia (CSMI) (0.66, 0.50-0.89), section modulus (SM) (0.40, 0.24-0.68) and cortical thickness (CT) (0.00, 0.00-0.01 due to rounding) were associated with decreased risk.”
Osteosarcopenia is linked with a higher risk of bone fracture in humans.
“Osteosarcopenia, probable sarcopenia and osteoporosis were all associated with increased risk of any fracture and mortality compared to the reference group.”
Osteosarcopenia is linked with a higher risk of bone fracture in humans (compared to males without osteopenia/osteoporosis or sarcopenia) (aOR 2.60, 95% CI 1.14, 5.91).
“and aOR 2.60, 95% CI 1.14, 5.91, respectively] compared to males without osteopenia/osteoporosis or sarcopenia.”
Humanscompared to males without osteopenia/osteoporosis or sarcopeniamalesn = 8,888
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·
Osteosarcopenia raises the risk of bone fracture in humans.
“This syndrome is associated with an increased risk of falls, fractures, functional impairment, hospitalization, and mortality”
Exercise lowers the risk of bone fracture in humans (IRR = 0.62, 95% CI 0.39–0.99).
“Although the study was primarily designed for falls and fall injuries, the secondary analysis showed a 38% lower fracture rate in the intervention group with the Poisson regression model (IRR = 0.62; CI95% 0.39–0.99, P = 0.047) and the Kaplan–Meier model (Log-rank P = 0.047).”
Exercise is linked with a higher risk of bone fracture in humans (highest quintile of LTPA volume) (OR 1.81, 95% CI 1.64-1.99).
“The strongest associations were in the highest quintile among men and women aged 40-49 years (OR 1.81, 95% CI 1.64-1.99 and OR 1.42, 95% CI 1.28-1.58 respectively).”
Humanshighest quintile of LTPA volumehighest quintileprevious five yearsmales
Exercise is associated with bone fracture in humans (Adjusted HR 0.848, 95% CI 0.771–0.932).
“the group that exercised before and after surgery showed a significant decrease in the risk of any fracture, vertebral fracture, and hip fracture”
HumansExercise before and after thyroidectomy for thyroid cancer versus no exercise before or after surgeryOnce a weekMedian follow-up of 4.5 yearsn = 74,774
Exercise lowers the risk of bone fracture in humans.
“Fall-related fractures were generally reduced by all types of exercises considered all together, but none singly resulted in statistically effective fracture prevention.”
Sarcopenia is associated with bone fracture in humans (determined by EWGSOP and AWGS 2019 criteria) (P < 0.05).
“sarcopenia, as determined by the EWGSOP and AWGS 2019 criteria, was associated with a moderate-to-high risk of major osteoporotic fractures and hip fractures within the next 10 years (P < 0.05).”
Humansdetermined by EWGSOP and AWGS 2019 criteria10 yearsn = 8,180
Sarcopenia is linked with a higher risk of bone fracture in humans (SDOC definition, adjusted for clinical risk factors used in FRAX) (HR: 1.48; 95% CI: 1.10, 1.99).
“Individuals with sarcopenia defined by SDOC had a higher risk for any fractures (HR: 1.48; 95% CI: 1.10, 1.99) and MOF (HR: 1.42; 95% CI: 1.03, 1.98) compared with individuals without sarcopenia”
HumansSDOC definition, adjusted for clinical risk factors used in FRAX6.4 ± 1.3 yrfemalesn = 2,883
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·
Sarcopenia is linked with a higher risk of bone fracture in humans (HR = 1.30 [1.08-1.56]).
“Presarcopenic (subgroups 1 and 2) and sarcopenic status were significantly associated with a higher risk of fracture (respectively adjusted HRs: HR = 1.26 [1.19-1.33], HR = 1.20 [1.11-1.30], HR = 1.30 [1.08-1.56])”
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·
Bone fracture is associated with mortality in humans (chronic kidney disease).
“fractures in this group are associated with exaggerated morbidity and mortality.”
Physical activity is linked with a lower risk of bone fracture in humans (compared with the inactive group) (HR = 0.899, 95% CI 0.824-0.981, P = 0.017).
“the WW pattern was associated with a lower hazard of incident fracture compared with both the inactive group (HR = 0.899, 95% CI 0.824-0.981, P = 0.017)”
Physical activity is linked with a higher risk of bone fracture in humans (HR 1.47, 95% CI 1.37-1.58).
“Higher levels of TPA were associated with an increased risk of fracture (quartile 3 [16.42-28.19 MET-h/day] HR 1.34, 95% CI 1.25-1.43; quartile 4 [> 28.19 MET-h/day] HR 1.47, 95% CI 1.37-1.58).”
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·
Physical activity is linked with a lower risk of bone fracture in humans (-30% risk of any fracture, -32% MOF, -54% hip fracture (Q4 vs Q1)).
“Women in Q4 vs. Q1 had 30% lower risk of any fracture, 32% lower risk of MOF, and 54% lower risk of hip fracture.”
Physical activity is linked with a lower risk of bone fracture in humans (cancer survivors 5 or more years after diagnosis) (HR 0.76, 95% CI 0.54-1.07).
“Although the HR for risk of fracture was lower among physically active cancer survivors 5 or more years after diagnosis (HR, 0.76; 95% CI, 0.54-1.07), this result was not statistically significant”
Humanscancer survivors 5 or more years after diagnosis
Physical activity lowers the risk of bone fracture in humans.
“regular PA, including moderate-to-vigorous intensity weight-bearing PA and resistance training activities, is consistently linked to greater BMD and reduced fracture risk.”
age is linked with a higher risk of bone fracture in humans with advancing age.
“In China, the disease burden of fall-related fractures among the elderly increased with advancing age, and the rate of this increase accelerated in older age groups.”
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·
Age is associated with bone fracture in humans (osteoporosis) (OR 1.081, 95% CI 1.012–1.155).
“Multivariate logistic regression identified age (OR = 1.081, 95% CI 1.012-1.155) and L2 FF (OR = 1.259, 95% CI 1.146-1.485)) as independent risk factors for fractures”
Age is associated with bone fracture in humans (participants without diabetes in the GLP-1 receptor agonist fracture-risk analysis) (OR 4.99 (95% CI 2.68–9.26) at 78–88 years).
“in this population, risk increased with age, reaching an odds ratio of 4.99 (95% CI 2.68–9.26) at 78–88 years.”
Reviewparticipants without diabetes in the GLP-1 receptor agonist fracture-risk analysis
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·
Thiazolidinediones
↑upin humans3↑upin reviews1HR 1.22
4 studies
Thiazolidinediones predict bone fracture in humans (type 2 diabetes and overweight or obesity) (HR 1.22; 95% CI, 1.02-1.46).
“Thiazolidinedione use (hazard ratio [HR] 1.22; 95% CI, 1.02-1.46) and insulin use (HR 1.34, 95% CI, 1.08-1.66) were significant diabetes-related predictors of all clinical fractures.”
Human trialtype 2 diabetes and overweight or obesity
Testosterone raises the risk of bone fracture in humans (hypogonadism, preexisting or high risk of cardiovascular disease) (HR 1.43, 95% CI 1.04 to 1.97).
“a clinical fracture had occurred in 91 participants (3.50%) in the testosterone group and 64 participants (2.46%) in the placebo group (hazard ratio, 1.43; 95% confidence interval, 1.04 to 1.97).”
Human trialhypogonadism, preexisting or high risk of cardiovascular diseasegelmedian follow-up of 3.19 yearsmalesn = 5,204
Testosterone raises the risk of bone fracture in humans (TRAVERSE trial) (hazard ratio 1.43).
“In the TRAVERSE fracture analysis, TRT did not lower fracture risk and a higher fracture incidence was reported in the TRT group (hazard ratio 1.43).”
Zoledronic acid lowers the risk of bone fracture in humans (RR 0.70, 95% CI 0.56-0.88).
“The relative risk of fragility fracture, any fracture, and major osteoporotic fracture was 0.72 (95% CI, 0.55 to 0.93), 0.70 (95% CI, 0.56 to 0.88), and 0.60 (95% CI, 0.42 to 0.86)”
Zoledronic acid lowers the risk of bone fracture in humans (non-osteoporotic women) (about 40% lower 10-year fracture risk).
“Zoledronate, administered preventively only twice at a five-year interval in recently menopausal, non-osteoporotic women, lowers 10-year fracture risk by about 40 %.”
Reviewnon-osteoporotic womentwice at a five-year interval10 yearsfemales
The Journal of clinical endocrinology and metabolism·
Insulin is associated with bone fracture in humans (type 2 diabetes).
“Several diabetes-related factors are associated with increased fracture risk, including exogenous insulin therapy, vascular complications, and poor glycaemic control”
Multicomponent intervention raises the risk of bone fracture in humans (OR = 2.39).
“The overall frequency of fractures due to falls was 2.7%, and, unexpectedly, subjects in the intervention group showed a higher risk compared to controls (OR = 2.39, p = 0.023).”
National Institute on Aging$73MNational Institute of Arthritis and Musculoskeletal and Skin Diseases$50.5MJapan Society for the Promotion of Science¥261M
Antiosteoporosis medications reduce fracture risk in pooled human trials. An exercise trial in women and a dairy-food trial also report reductions, whereas a multicomponent-intervention trial reports increased risk. Observational studies link frailty and dementia with higher fracture risk; a supplement trial finds no clear effect of multivitamin-multimineral supplements or cocoa extract.
Human trials report fewer fractures with antiosteoporosis medications and dairy foods, and an exercise trial reports fewer fractures in women. Multivitamins, cocoa extract, and multifactorial fall prevention show no clear effect, while a multicomponent intervention increases fractures. Human cohorts link frailty, dementia, and underweight with higher fracture risk, and physical activity and healthy sleep with lower risk.
Summary rewritten as its findings changed.
As it read before
Frailty and osteosarcopenia are linked with higher fracture risk in human cohorts. Human trials report fewer fractures with antiosteoporosis medications and dairy foods, and a trial in women reports fewer with exercise. A multicomponent intervention increases fractures in a trial, while multivitamin–multimineral supplements and cocoa extract show no clear effect on fractures in another.
Antiosteoporosis medications reduce fracture risk in human trials; individual trials also report reductions with dairy foods and, in women, exercise. Human cohorts associate frailty and underweight with higher fracture risk. A trial reports increased fractures with a multicomponent intervention, while another shows no clear effect of multivitamin-mineral supplements or cocoa extract.
Human cohorts link frailty with higher fracture risk. Human trials report fewer fractures with antiosteoporosis medications and dairy foods, and an exercise trial reports fewer fractures in women. A multicomponent intervention increases fracture risk, while multivitamin–multimineral supplementation, cocoa extract and multifactorial fall prevention show no clear effect.
Osteoporosis risk was 52% higher in metabolically healthy normal-weight people and 57% higher in metabolically unhealthy normal-weight people than in metabolically…Osteoporosis risk was 52% higher in metabolically healthy normal-weight people and 57% higher in metabolically unhealthy normal-weight people than in metabolically healthy overweight or obese people.
Who was studied163,252 UK Biobank participants, median 13.74 years
What changedNormal-weight people had 52% higher osteoporosis risk when metabolically healthy and 57% higher when unhealthy than metabolically healthy overweight/obese people
The catchThe Chinese REACTION analysis did not detect statistically clear associations with osteoporosis or fractures
In a 45-day experiment, deoxycholic acid improved bone structure in mice whose ovaries had been removed to model bone loss after menopause.In a 45-day experiment, deoxycholic acid improved bone structure in mice whose ovaries had been removed to model bone loss after menopause.